Targeting Sphingosine Kinase 1 for the Treatment of Pulmonary Hypertension
Fields of Study & Subjects
Pulmonary Hypertension Research and Treatments
Sphingolipid Metabolism and Signaling
Systemic Sclerosis and Related Diseases
Publication details
- Journal / source
- Therapeutic Innovation Australia
- Publication date
- 16 February 2026
- Language
- EN